1. Home
  2. NL vs SLP Comparison

NL vs SLP Comparison

Compare NL & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NL Industries Inc.

NL

NL Industries Inc.

HOLD

Current Price

$5.68

Market Cap

283.9M

Sector

Industrials

ML Signal

HOLD

Logo Simulations Plus Inc.

SLP

Simulations Plus Inc.

HOLD

Current Price

$17.95

Market Cap

322.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NL
SLP
Founded
1891
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
283.9M
322.4M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
NL
SLP
Price
$5.68
$17.95
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$27.25
AVG Volume (30 Days)
36.8K
247.1K
Earning Date
11-06-2025
01-08-2026
Dividend Yield
10.27%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$159,004,000.00
$79,179,000.00
Revenue This Year
$15.75
$2.42
Revenue Next Year
$2.44
$7.05
P/E Ratio
$27.97
N/A
Revenue Growth
5.52
13.09
52 Week Low
$5.04
$12.39
52 Week High
$9.27
$37.67

Technical Indicators

Market Signals
Indicator
NL
SLP
Relative Strength Index (RSI) 53.82 42.68
Support Level $5.34 $17.73
Resistance Level $5.72 $19.78
Average True Range (ATR) 0.23 0.75
MACD 0.01 -0.12
Stochastic Oscillator 68.42 5.85

Price Performance

Historical Comparison
NL
SLP

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: